With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...

Cognito's $105 million Series C will advance their pivotal FDA study, expand clinical neurology partnerships, and expand work past Alzheimer's into Parkinsons and beyond.

A number of pivotal announcements this year – including Neuralink’s first brain implant trial, and major funding rounds from companies such as Motif Neurotech with its miniaturized neurostimulator for ...

ARLINGTON, Va.--(BUSINESS WIRE)--At CES, AI is everywhere — it’s the buzzword at every booth and in every pitch. But beyond the flashy demos, what does AI truly mean for brands right now? Modev will ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Swan NeuroTech, a company ...

Please provide your email address to receive an email when new articles are posted on . Following two successful phase 3 studies, Neurotech is preparing to submit a license application for NT-501 to ...

Technological advancements in various fields of science are shattering what some scientists once deemed impossible. In recent years, researchers have mitigated the existential threat of asteroids, ...

Please provide your email address to receive an email when new articles are posted on . Neurotech submitted a biologics license application for its macular telangiectasia therapy, NT-501, to the FDA ...